X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (59) 59
cardiac & cardiovascular systems (55) 55
humans (49) 49
index medicus (46) 46
male (44) 44
female (43) 43
middle aged (41) 41
abridged index medicus (35) 35
aged (34) 34
heart attacks (34) 34
stents (34) 34
cardiology (29) 29
treatment outcome (27) 27
angioplasty (25) 25
cardiology and cardiovascular medicine (25) 25
mortality (24) 24
percutaneous coronary intervention (23) 23
transluminal angioplasty (22) 22
follow-up studies (21) 21
heart attack (21) 21
optical coherence tomography (20) 20
coronary angiography (19) 19
stent (19) 19
time factors (18) 18
cardiac patients (17) 17
coronary vessels (17) 17
myocardial infarction - therapy (17) 17
prognosis (17) 17
myocardial infarction - mortality (16) 16
drug-eluting stents (15) 15
electrocardiography (15) 15
prospective studies (15) 15
thrombosis (15) 15
primary angioplasty (14) 14
internal medicine (13) 13
myocardial infarction - surgery (13) 13
care and treatment (12) 12
medical colleges (12) 12
myocardial infarction (12) 12
patient outcomes (12) 12
acute myocardial-infarction (11) 11
angioplasty, balloon, coronary (11) 11
clinical outcomes (11) 11
intravascular ultrasound (11) 11
coronary artery bypass (10) 10
drug therapy (10) 10
outcomes (10) 10
acute coronary syndromes (9) 9
bivalirudin (9) 9
impact (9) 9
implantation (9) 9
medical imaging (9) 9
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (9) 9
risk factors (9) 9
acute myocardial infarction (8) 8
cardiovascular disease (8) 8
comparative analysis (8) 8
coronary artery disease (8) 8
myocardial infarction - physiopathology (8) 8
risk (8) 8
survival rate - trends (8) 8
bare-metal stents (7) 7
heparin - therapeutic use (7) 7
kaplan-meier estimate (7) 7
myocardial infarction - diagnosis (7) 7
platelet aggregation inhibitors - therapeutic use (7) 7
restenosis (7) 7
ultrasonography, interventional (7) 7
united states - epidemiology (7) 7
veins & arteries (7) 7
abciximab (6) 6
angioplasty, balloon, coronary - adverse effects (6) 6
confidence intervals (6) 6
coronary heart disease (6) 6
coronary vessels - pathology (6) 6
drug-eluting stent (6) 6
follow-up (6) 6
myocardial infarction - complications (6) 6
paclitaxel-eluting stents (6) 6
pci (6) 6
reperfusion (6) 6
survival analysis (6) 6
analysis (5) 5
angiography (5) 5
angioplasty, balloon, coronary - methods (5) 5
bleeding (5) 5
clinical trials (5) 5
clinical-outcomes (5) 5
coronary restenosis - prevention & control (5) 5
coronary vessels - diagnostic imaging (5) 5
drug therapy, combination (5) 5
harmonizing outcomes (5) 5
heparin (5) 5
heparin - administration & dosage (5) 5
incidence (5) 5
intervention (5) 5
medicine, general & internal (5) 5
peptide fragments - therapeutic use (5) 5
percutaneous coronary intervention - methods (5) 5
predictive value of tests (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10060, pp. 2618 - 2628
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 6, pp. 869 - 870
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 23, pp. 2556 - 2566
Objectives The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes... 
Cardiovascular | Internal Medicine | mortality | bleeding | myocardial infarction | risk score | STRATEGY ACUITY TRIAL | ISCHEMIC EVENTS | ELUTING STENT | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE CATHETERIZATION | GLOBAL REGISTRY | RANDOMIZED-TRIAL | GLYCOPROTEIN IIB/IIIA INHIBITORS | ACUTE MYOCARDIAL-INFARCTION | UNSTABLE ANGINA | CLINICAL-OUTCOMES | Multivariate Analysis | Predictive Value of Tests | Confidence Intervals | Platelet Glycoprotein GPIIb-IIIa Complex - adverse effects | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Heparin - therapeutic use | Male | Heparin - adverse effects | Cause of Death | Hospital Mortality - trends | Fibrinolytic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Electrocardiography | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Severity of Illness Index | Coronary Artery Bypass - methods | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Kaplan-Meier Estimate | Proportional Hazards Models | Probability | Treatment Outcome | Acute Coronary Syndrome - drug therapy | Coronary Angiography | Acute Coronary Syndrome - diagnosis | Survival Analysis | Platelet Glycoprotein GPIIb-IIIa Complex - therapeutic use | Acute Coronary Syndrome - therapy | Aged | Hemorrhage - chemically induced | Transluminal angioplasty | Sects | Medical research | Coronary artery bypass | Cardiac patients | Mortality | Medicine, Experimental | Health aspects | Coronary heart disease | Risk factors | Medical colleges | Blood transfusions | Heart attacks | Medical imaging | Blood products | Data bases | Confidence intervals | Biomarkers | Intubation | Acute coronary syndromes | Age | Logistics
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2193 - 2204
Summary Background Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes. Methods... 
Internal Medicine | HARMONIZING OUTCOMES | MEDICINE, GENERAL & INTERNAL | BLOOD-TRANSFUSION | DOUBLE-BLIND | FOLLOW-UP | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PREMATURE DISCONTINUATION | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Confidence Intervals | Myocardial Infarction - mortality | Paclitaxel - pharmacology | Prospective Studies | Follow-Up Studies | Humans | Heparin - administration & dosage | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - therapy | Platelet Glycoprotein GPIIb-IIIa Complex - administration & dosage | Time Factors | Electrocardiography | Female | Drug Therapy, Combination | Stents | Angioplasty, Balloon - methods | Myocardial Infarction - diagnosis | Drug-Eluting Stents | Drug Administration Schedule | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon - mortality | Hirudins - adverse effects | Survival Analysis | Peptide Fragments - adverse effects | Bivalirudin | Research | Diagnosis | Heparin | Drug therapy | Comparative analysis | Health aspects | Heart attack | Heart attacks | Cardiology | Mortality
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9696, pp. 1149 - 1159
Summary Background In the HORIZONS-AMI trial, patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | GLYCOPROTEIN IIB/IIIA BLOCKADE | BLOOD-TRANSFUSION | RISK | ACUTE CORONARY SYNDROMES | ACUITY TRIAL | ABCIXIMAB | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Recombinant Proteins - therapeutic use | Myocardial Infarction - mortality | Follow-Up Studies | Humans | Middle Aged | Heparin - therapeutic use | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Aged, 80 and over | Adult | Female | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Hemorrhage - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Anticoagulants - therapeutic use | Survival Rate | Treatment Outcome | Anticoagulants - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Myocardial Infarction - drug therapy | Thrombosis - etiology | Hirudins - adverse effects | Aged | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Stents - adverse effects | Care and treatment | Angioplasty | Patient outcomes | Bivalirudin | Dosage and administration | Health aspects | Heart attack | Clinical trials | Cardiovascular disease | Heart attacks | Drug therapy | Mortality
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 8, pp. 1072 - 1081
Journal Article
Interventional cardiology clinics, 07/2015, Volume 4, Issue 3, p. 251
Coronary angiography confirms or excludes coronary artery disease, assesses lesions severity, and helps to decide percutaneous coronary interventions (PCI).... 
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2010, Volume 3, Issue 5, pp. 531 - 539
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 3, pp. 228 - 236
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 157, Issue 3, pp. 569 - 575.e1
Journal Article